Org.nr 815 643 062 2021 → 2022 Year-over-year analysis

ADESSO BIOPRODUCTS AS: årsregnskap 2022 vs 2021

Grew 41% on revenue, stronger earnings

approved 2023-03-29; registry 2023-04-11; journal 2023 345004

Summary

What changed

Comparing Årsregnskap 2022 with 2021 for ADESSO BIOPRODUCTS AS. Revenue 74.98m NOK → 105.37m NOK (+40.5%). Net result +3.93m NOK → +5.21m NOK.

On the constructive side: revenue rose; operating result improved; net result improved.

Also worth watching: cogs moved. All figures are taken from the published annual accounts for ADESSO BIOPRODUCTS AS.

At a glance

Revenue

74.98m NOK 105.37m NOK

+40.5%

Operating result

+5.15m NOK +7.02m NOK

+36.3%

Net result

+3.93m NOK +5.21m NOK

+32.4%

Equity

n/m 37.85m NOK

—

Cash

13.29m NOK 21.65m NOK

+63.0%

Total assets

81.18m NOK 80.63m NOK

-0.7%

↑
Revenue rose

Operating income / revenue moved from 74.98m NOK to 105.37m NOK (+40.5% YoY). Calculated
↑
Operating result improved

Operating result +5.15m NOK → +7.02m NOK (op. margin 6.9% → 6.7%). Calculated
↑
Net result improved

Net result +3.93m NOK → +5.21m NOK (net margin 5.2% → 4.9%). Calculated
↑
Cash rose

Bank deposits 13.29m NOK → 21.65m NOK (+63.0% YoY). Calculated

·
COGS moved

COGS / varekostnad 37.47m NOK → 60.18m NOK (+60.6% YoY). Calculated